
Customize View
Recently disclosed strategic alliances only (within the last two years)
Include Strategic Alliances for:Current subsidiaries



Strategic Alliances

Recently Disclosed Strategic Alliances
Strategic Alliance Name
Primary Industry
Source
U.S. Army Medical Research Institute of Infectious Diseases
Research and Consulting Services
Vaxil Bio Ltd. (TSXV:VXL) 2022 Form Doc
Business Description: U.S. Army Medical Research Institute of Infectious Diseases provides laboratory research and development services for medical biological defense catering to military and government sectors. It researches, develops, tests, and evaluates vaccines, drugs, and diagnostic solutions to protect military personnel and civilians from infectious diseases and biological threats. It also offers information to protect people from biological threats such as anthrax, botulism, plague, Ebola, Marburg hemorrhagic fevers, hantavirus, ricin toxin, and staphylococcal enterotoxin B. The company also develops diagnostic assays for medical identification to protect the war fighter against biological threats; and diagnostic instruments and technologies for use in forward field medical laboratories. In addition, it offers training and education programs in the areas of medical management of chemical and biological casualties; maintenance of bio-safety, bio-surety and bio-security standards; field identification of biological warfare agents; and biological agent identification and counterterrorism. U.S. Army Medical Research Institute of Infectious Diseases was founded in 1969 and is based in Frederick, Maryland.
*denotes proprietary relationship